Welltower (NYSE:WELL) was upgraded by equities research analysts at BMO Capital Markets from an “underperform” rating to a “market perform” rating in a report issued on Friday, The Fly reports.
Other research analysts also recently issued reports about the company. Stephens reissued a “buy” rating and issued a $61.00 price objective on shares of Welltower in a research note on Tuesday, February 27th. SunTrust Banks set a $58.00 price objective on Welltower and gave the company a “hold” rating in a research note on Friday, February 23rd. ValuEngine downgraded Welltower from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Bank of America dropped their price objective on Welltower from $67.00 to $58.00 and set a “neutral” rating on the stock in a research note on Thursday, March 8th. Finally, JPMorgan Chase reissued a “neutral” rating and issued a $67.00 price objective (down from $71.00) on shares of Welltower in a research note on Friday, March 16th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $63.00.
Shares of Welltower opened at $53.93 on Friday, MarketBeat reports. The stock has a market capitalization of $20.40 billion, a PE ratio of 12.81, a price-to-earnings-growth ratio of 2.28 and a beta of 0.18. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.75 and a current ratio of 1.75. Welltower has a 1 year low of $54.67 and a 1 year high of $55.26.
Welltower (NYSE:WELL) last announced its quarterly earnings data on Thursday, April 26th. The real estate investment trust reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.17. The company had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.09 billion. Welltower had a return on equity of 5.13% and a net margin of 14.60%. The firm’s revenue was up 3.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.05 EPS. equities research analysts forecast that Welltower will post 4.02 EPS for the current fiscal year.
In other news, Director Kenneth J. Bacon purchased 600 shares of the company’s stock in a transaction that occurred on Thursday, March 15th. The shares were acquired at an average cost of $53.63 per share, with a total value of $32,178.00. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Gary Whitelaw purchased 925 shares of the company’s stock in a transaction that occurred on Tuesday, May 1st. The shares were purchased at an average cost of $54.18 per share, for a total transaction of $50,116.50. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 3,387 shares of company stock worth $182,116. 0.17% of the stock is owned by company insiders.
Hedge funds have recently bought and sold shares of the stock. Swiss National Bank acquired a new position in Welltower during the 1st quarter worth approximately $79,515,000. Brighton Jones LLC bought a new stake in Welltower during the 1st quarter worth approximately $254,000. CFO4Life Group LLC bought a new stake in Welltower during the 1st quarter worth approximately $224,000. Schwab Charles Investment Management Inc. bought a new stake in Welltower during the 1st quarter worth approximately $205,322,000. Finally, Stephens Inc. AR bought a new stake in Welltower during the 1st quarter worth approximately $7,184,000. 87.37% of the stock is currently owned by institutional investors and hedge funds.
Welltower Inc (NYSE:HCN), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.